351 related articles for article (PubMed ID: 35833396)
41. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.
Januzzi JL; van Kimmenade R; Lainchbury J; Bayes-Genis A; Ordonez-Llanos J; Santalo-Bel M; Pinto YM; Richards M
Eur Heart J; 2006 Feb; 27(3):330-7. PubMed ID: 16293638
[TBL] [Abstract][Full Text] [Related]
42. Amino-terminal pro-brain natriuretic peptid in prediction of left ventricular ejection fraction.
Bajrić M; Baraković F; Kusljugić Z; Salkić N; Jahić E; Ascerić M; Ljuca F; Mrsić D; Smajić E; Caluk J; Hajrić R
Bosn J Basic Med Sci; 2008 Aug; 8(3):282-6. PubMed ID: 18816264
[TBL] [Abstract][Full Text] [Related]
43. Effects of ivabradine therapy on heart failure biomarkers.
Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
[TBL] [Abstract][Full Text] [Related]
44. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
45. Establishment of normal reference values of NT-proBNP and its application in diagnosing acute heart failure in children with severe hand foot and mouth disease [corrected].
Li S; Xiao Z; Li L; Hu B; Zhou Z; Yi S; Luo J; Xie L; Nie B; Mo L; Wang S
Medicine (Baltimore); 2018 Sep; 97(36):e12218. PubMed ID: 30200140
[TBL] [Abstract][Full Text] [Related]
46. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).
Bhatt AS; Cooper LB; Ambrosy AP; Clare RM; Coles A; Joyce E; Krishnamoorthy A; Butler J; Felker GM; Ezekowitz JA; Armstrong PW; Hernandez AF; O'Connor CM; Mentz RJ
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29431103
[TBL] [Abstract][Full Text] [Related]
47. Impact of age and renal function on usefulness of NT-proBNP to diagnose heart failure
.
Charmetant X; Pecquet M; Poirié P; Agi D; Aupetit JF; Villar E
Clin Nephrol; 2019 Aug; 92(2):65-72. PubMed ID: 31198167
[TBL] [Abstract][Full Text] [Related]
48. Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions.
Pan W; Yang D; Yu P; Yu H
BMC Cardiovasc Disord; 2020 Apr; 20(1):208. PubMed ID: 32354356
[TBL] [Abstract][Full Text] [Related]
49. Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea.
Sanz MP; Borque L; Rus A; Vicente B; Ramírez Y; Lasa L
J Clin Lab Anal; 2006; 20(6):227-32. PubMed ID: 17115420
[TBL] [Abstract][Full Text] [Related]
50. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
[TBL] [Abstract][Full Text] [Related]
51. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
52. Low NT-proBNP levels: An early sign for the diagnosis of ischemic heart failure.
Zheng YR; Ye LF; Cen XJ; Lin JY; Fu JW; Wang LH
Int J Cardiol; 2017 Feb; 228():666-671. PubMed ID: 27883979
[TBL] [Abstract][Full Text] [Related]
53. Correlation between NT proBNP and left ventricular ejection fraction in elderly patients presenting to emergency department with dyspnoea.
Belagavi AC; Rao M; Pillai AY; Srihari US
Indian Heart J; 2012; 64(3):302-4. PubMed ID: 22664815
[TBL] [Abstract][Full Text] [Related]
54. Effect of renal failure on N-terminal Pro-Brain natriuretic peptide in patients admitted to emergency department with acute dyspnea.
Çolak A; Çuhadar S; Gölcük B; Gölcük Y; Özdoğan Ö; Çoker I
Anadolu Kardiyol Derg; 2014 Sep; 14(6):519-24. PubMed ID: 25233498
[TBL] [Abstract][Full Text] [Related]
55. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
Berdagué P; Caffin PY; Barazer I; Vergnes C; Sedighian S; Letrillard S; Pilossof R; Goutorbe F; Piot C; Reny JL
Am Heart J; 2006 Mar; 151(3):690-8. PubMed ID: 16504634
[TBL] [Abstract][Full Text] [Related]
56. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
[TBL] [Abstract][Full Text] [Related]
57. N-terminal pro-brain natriuretic peptide is a useful marker to identify latent heart failure patients in older adults in a rural outpatient clinic.
Hamagawa K; Kubo T; Nishimura K; Baba Y; Hirota T; Yamasaki N; Kitaoka H
Geriatr Gerontol Int; 2017 Oct; 17(10):1648-1653. PubMed ID: 27860152
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic significance of NT-proBNP estimation in patients with acute dyspnea.
Shaikh K; Ahmad M
J Coll Physicians Surg Pak; 2011 Oct; 21(10):584-8. PubMed ID: 22015116
[TBL] [Abstract][Full Text] [Related]
59. Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality.
Christenson RH; Azzazy HM; Duh SH; Maynard S; Seliger SL; Defilippi CR
Clin Chem; 2010 Apr; 56(4):633-41. PubMed ID: 20167699
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.
Butt JH; Adamson C; Docherty KF; de Boer RA; Petrie MC; Inzucchi SE; Kosiborod MN; Maria Langkilde A; Lindholm D; Martinez FA; Bengtsson O; Schou M; O'Meara E; Ponikowski P; Sabatine MS; Sjöstrand M; Solomon SD; Jhund PS; McMurray JJV; Køber L
Circ Heart Fail; 2021 Dec; 14(12):e008837. PubMed ID: 34802253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]